Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESWT with PRP vs ESWT with Placebo for Resistant Plantar Fasciitis
NCT02668510Withdrawn
- Start
- Jan 2016
- Primary completion
- Dec 2023
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Randomised, double-blind trial in plantar fasciitis comparing Platelet Rich Plasma Injection Group with Placebo injection group (2 arms). Primary endpoint: Visual Analog Scale at 24 weeks. Planned start Jan 2016; status: withdrawn.
02
Drugs
autologous platelet-rich plasma
03
Conditions
plantar fasciitis
Beyond the preview
Go deeper on NCT02668510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02668510.